Article
Antidiabetic thiazolidinediones induce ductal differentiation but not apoptosis in pancreatic cancer cells.
World journal of gastroenterology - 28 Feb 2005
Ceni Elisabetta, Mello Tommaso, Tarocchi Mirko, Crabb David-W, Caldini Anna, Invernizzi Pietro, Surrenti Calogero, Milani Stefano, Galli Andrea
Abstract excerpt
AIM: Thiazolidinediones (TZD) are a new class of oral antidiabetic drugs that have been shown to inhibit growth of same epithelial cancer cells. Although TZD were found to be ligands for peroxisome proliferator-activated receptor gamma (PPARgamma), the mechanism by which TZD exert their anticancer effect is presently unclear. In this study, we analyzed the mechanism by which TZD inhibit growth of human pancreatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
